Groups | Baseline | Reperfusion, min |
|---|
| | | 5 | 30 | 60 | 120 |
CON-22 (n=7) | 243±16 | 215±21 | 218±22 | 238±28 | 222±35 |
mKHB-22 (n=7) | 253±25 | 218±32 | 219±29 | 246±34 | 251±28 |
STH2-22 (n=6) | 256±14 | 227±28 | 216±22 | 245±35 | 236±32 |
CON-37 (n=7) | 250±23 | - | 187±39 | 212±52 | 242±68 |
mKHB-37 (n=5) | 268±21 | 191±39 | 195±24 | 211±32 | 232±58 |
STH2-37 (n=6) | 269±13 | 180±35 | 187±37 | 223±47 | 224±12 |
- Data are mean ± SD. Group legends in hypothermia series: controls subjected to 180-min ischemia and 120-min reperfusion (CON-22), cardioplegia with modified Krebs-Henseleit buffer-based cardioplegic solution (mKHB-22), cardioplegia with St Thomas’ Hospital cardioplegic solution №2 (STH2-22). Group legends in normothermia series: controls subjected to 60-min ischemia and 120-min reperfusion (CON-37), cardioplegia with modified Krebs-Henseleit buffer-based cardioplegic solution (mKHB-37), cardioplegia with St Thomas’ Hospital cardioplegic solution №2 (STH2-37).
- “-” - persistent ventricular fibrillation/asystole in all hearts.
